Skip to main content

Table 1 Patients’ characteristics at the time of surgery (n = 24)

From: Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC

  Mean Range
Age (years) 65.29 47–78
Sex Frequency %
 Male 14 58.3
 Female 10 41.7
Histologic type Frequency %
 Adenocarcinoma 22 91.7
 Squamous cell 2 8.3
Surgery Frequency %
 Lobectomy 20 83.5
 Sublobar resection 4 16.5
Lymphadenectomy Frequency %
 Yes 21 87.5
 No 3 12.5
pT stage Frequency %
 pT1 9 37.5
 pT2 11 45.8
 pT3 1 4.2
 pT4 3 12.5
pN stage Frequency %
 pN0 17 70.8
 pN1 6 25.0
 pN2 1 4.2
TNM Classification 8th Ed   
 I 6 25.0
 IIA 5 20.8
 IIB 8 33.4
 IIIA 5 20.8
(Neo)Adjuvant treatment at the time of surgery   
 None 16 66.6
 Adjuvant 4 16.7
 Neoadjuvant 4 16.7